3 UK Stocks Estimated To Be Undervalued By Up To 48.1%

The United Kingdom's FTSE 100 index has recently faced challenges, closing lower due to weak trade data from China and concerns about global economic recovery. In such a volatile market environment, identifying undervalued stocks can be crucial for investors seeking potential opportunities, as these stocks may offer value despite broader market fluctuations.

Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom

Name	Current Price	Fair Value (Est)	Discount (Est)
Dr. Martens (LSE:DOCS)	£0.6315	£1.20	47.5%
GlobalData (AIM:DATA)	£1.805	£3.37	46.5%
Victrex (LSE:VCT)	£9.46	£18.23	48.1%
Deliveroo (LSE:ROO)	£1.302	£2.50	47.9%
Ibstock (LSE:IBST)	£1.648	£3.08	46.6%
Likewise Group (AIM:LIKE)	£0.195	£0.37	47.6%
Foxtons Group (LSE:FOXT)	£0.614	£1.22	49.8%
Kromek Group (AIM:KMK)	£0.06	£0.11	47.5%
Calnex Solutions (AIM:CLX)	£0.55	£1.04	46.9%
Melrose Industries (LSE:MRO)	£6.80	£12.67	46.3%

Click here to see the full list of 53 stocks from our Undervalued UK Stocks Based On Cash Flows screener.

Below we spotlight a couple of our favorites from our exclusive screener.

GlobalData (AIM:DATA)

Overview: GlobalData Plc, with a market cap of £1.43 billion, provides proprietary data, analytics, and insights across Europe, North America, and the Asia Pacific.

Operations: The company's revenue segment, amounting to £276.80 million, is derived from its provision of business information through data, analytics, and insights across its operational regions.

Estimated Discount To Fair Value: 46.5%

GlobalData is trading at £1.81, significantly below its estimated fair value of £3.37, suggesting it may be undervalued based on cash flows. The company's earnings are expected to grow significantly at 23.1% per year, outpacing the UK market's 14.1%. Despite insider selling and a dividend not fully covered by earnings, GlobalData plans a £50 million share buyback and aims to move from AIM to the Main Market for broader investor access.

• In light of our recent growth report, it seems possible that GlobalData's financial performance will exceed current levels.
• Unlock comprehensive insights into our analysis of GlobalData stock in this financial health report.

Ibstock (LSE:IBST)

Overview: Ibstock plc manufactures and sells clay and concrete building products and solutions to the residential construction sector in the United Kingdom, with a market cap of £649.33 million.

Operations: The company's revenue is derived from two main segments: Clay products generating £249.97 million and Concrete products contributing £111.32 million.

Estimated Discount To Fair Value: 46.6%

Ibstock is trading at £1.65, well below its estimated fair value of £3.08, indicating potential undervaluation based on cash flows. Despite a drop in net income to £15.09 million for 2024 and lower profit margins, earnings are projected to grow significantly at 37.2% annually over the next three years, surpassing UK market expectations. However, the dividend yield of 4.25% isn't fully covered by earnings or cash flows, signaling caution for income-focused investors.

• Upon reviewing our latest growth report, Ibstock's projected financial performance appears quite optimistic.
• Dive into the specifics of Ibstock here with our thorough financial health report.

Victrex (LSE:VCT)

Overview: Victrex plc, with a market cap of £822.63 million, manufactures and sells polymer solutions globally through its subsidiaries.

Operations: The company generates revenue from its segments, with Medical contributing £53 million and Sustainable Solutions accounting for £240.60 million.

Estimated Discount To Fair Value: 48.1%

Victrex is trading at £9.46, significantly below its estimated fair value of £18.23, highlighting potential undervaluation based on cash flows. While profit margins have decreased from 20.1% to 5.9%, earnings are forecast to grow substantially at 30.44% annually over the next three years, outpacing UK market expectations. However, the dividend yield of 6.3% isn't adequately covered by earnings or free cash flows, requiring careful consideration for income investors.

• Our expertly prepared growth report on Victrex implies its future financial outlook may be stronger than recent results.
• Click here and access our complete balance sheet health report to understand the dynamics of Victrex.

Seize The Opportunity

• Discover the full array of 53 Undervalued UK Stocks Based On Cash Flows right here.
• Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
• Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Looking For Alternative Opportunities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com